BiotechTube
Home/AlzeCure Pharma/Martin Jönsson
MJ

Martin Jönsson

Chief Executive Officer (CEO)

AlzeCure Pharma

Therapeutic Areas

Alzheimer's DiseaseCognitive DisordersNeuropathic PainOsteoarthritis Pain

AlzeCure Pharma Pipeline

DrugIndicationPhase
NeuroRestore ACD856Alzheimer's Disease (Cognitive Symptoms)Phase 2
Alzstatin ProgramAlzheimer's Disease (Disease Modification)Pre-clinical
Painless ACD440Neuropathic Pain / ErythromelalgiaPhase 2
Painless TrkA-NAMSevere Pain (e.g., Osteoarthritis)Pre-clinical

Leadership Team at AlzeCure Pharma

JS
Johan Sandin
Chief Scientific Officer (CSO)
BL
Birgitta Lundvik
Chief Financial Officer (CFO)
View full AlzeCure Pharma profile